CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering CytoSorbents Strengthens Balance Sheet with $10.3M Registered Direct Offering. Insiders invest $435,000

ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering WESTMINSTER, Colo., June 03, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) a late stage biopharmaceutical company applying a precision medicine approach to developing genetically...

VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million CAMBRIDGE, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...

LegalMinds/NASDAQ Securities & Capital Market Series Interview: Morrison & Foerster Partner James Tanenbaum Discusses Advantages of Hybrid Financing to Raise Capital in Uncertain Market Conditions New York, Jan. 24, 2011 (GLOBE NEWSWIRE) -- In response to the continued volatility and uncertainty in the public markets, there has been an increase in popularity of hybrid financing vehicles such...